Construction firm Robins & Morton has begun work on the new Carilion Taubman Cancer Center in Roanoke, Virginia.
The six-story, nearly 257,000-square-foot cancer center will bring together personalized care, advanced technology and treatment options, sophisticated clinical trials, and cutting-edge research in a single location. It has been designed to accommodate more patients than the current facility and support the healing process with natural light, outdoor spaces, and expanded amenities.
Carilion Clinic is the leading healthcare provider for Western Virginia, serving nearly 1 million patients annually. The new facility will be located on Carilion’s Riverside Campus, shared with partners Virginia Tech Carilion School of Medicine and Fralin Biomedical Research Institute at VTC.
“The Carilion Taubman Cancer Center represents a major milestone for our region – where cancer care needs are only increasing,” said Steve Arner, President and CEO of Carilion. “This cutting-edge facility will offer more experts and expanded care options so our communities can receive the life-saving care they deserve close to home.”
“We are honored to bring this state-of-the-art cancer center to Roanoke,” Robins & Morton Vice President Mark Mattox said. “At Robins & Morton, we understand the profound impact that such a facility will have on our community, providing essential cancer treatment services. Our team is fully committed to delivering a project that not only meets but exceeds the expectations of Carilion Clinic and its future patients.”
The project is scheduled for completion in 2027.
The general contractor is Robins & Morton Branch Builds, a joint venture partnership. HDR is the architect.
